Caribou Biosciences

Biotechnology

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPRplatform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

CRBU

Visualizar Fundamentos

Caribou Biosciences

0,9

P/B

8,1

P/S

—

P/EBITDA

—

Forward P/E

4,1

BVPS

—

EPS